Building an Investable Proposition

We are hosting an exclusive breakfast roundtable session in collaboration with One Nucleus and tranScrip.

If you're an emerging company leader, take the chance to share your thoughts and concerns peer-to-peer around how to create and pitch your value proposition to investors and Pharma. We know that investors now expect a lot of prep work form biotech companies so they can truly evaluate the current status and route to further value creation. Many of the factors are related to what gets uncovered in due diligence around topics such as IP protection, clinical development plans, leadership teams and commercialisation strategy.

The format will be an interactive roundtable discussion facilitated by Gareth Probert and Tim Belcher from EIP and Linda Summerton from tranScrip.

Agenda:

08:00 Arrival
08:20 Introduction to the session followed by roundtable discussion about assembling the key elements of a compelling value proposition. To include:

- Key elements of IP strategy

- Clinical development path

- Building the right team

- Commercialisation plan

- What to expect in due diligence

- How is your homework marked?

09:25 Wrap up
09:30 Close

Registration:

This event is designed for primary R&D biotech companies.

Attendance at this event is free of charge and by invitation only.

To express your interest in attending, please contact alicia@onenucleus.com at your earliest convenience.